NCT01960569View on ClinicalTrials.gov

Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas

PHASE4UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

April 30, 2014

Conditions
r-Hirudin (Thrombexx) Efficacy in Treatment of Haematomas
Interventions
DRUG

active product ( Thrombexx) assigned to arm 1

Dispense 2-3 cm of cream or gel, 2-3 times per day and carry out a light massage until complete

OTHER

Placebo assigned to arm 2

Trial Locations (1)

Unknown

RECRUITING

Prof. Mahmoud Hafez, Cairo

Sponsors
All Listed Sponsors
lead

MinaPharm Pharmaceuticals

INDUSTRY